Evidence-Based Practice: Research Appraisal and Quality Improvement

Clinical meaning

Evidence-based practice (EBP) is the conscientious, explicit, and judicious integration of best research evidence with clinical expertise and patient values in making clinical decisions (Sackett, 1996). The EBP process follows five steps (the 5 A's): (1) ASK a focused clinical question (PICO format), (2) ACQUIRE the best available evidence through systematic literature searching, (3) APPRAISE the evidence critically for validity, relevance, and applicability, (4) APPLY the evidence integrated with clinical expertise and patient preferences, and (5) ASSESS the outcomes of the evidence application. CRITICAL APPRAISAL requires understanding the HIERARCHY OF EVIDENCE: Level I -- systematic reviews and meta-analyses of randomized controlled trials (RCTs); Level II -- well-designed RCTs; Level III -- controlled trials without randomization; Level IV -- cohort and case-control studies; Level V -- systematic reviews of descriptive/qualitative studies; Level VI -- single descriptive or qualitative studies; Level VII -- expert opinion. The NP must appraise research methodology: INTERNAL VALIDITY (was the study designed and conducted rigorously enough that the results are trustworthy?) assessed by evaluating randomization, blinding, sample size/power calculation, intention-to-treat analysis, attrition rates, and potential biases; EXTERNAL VALIDITY (are the results applicable to my patient?) assessed by comparing the study population to the NP's patient in terms of demographics, comorbidities, setting, and intervention feasibility. KEY STATISTICAL CONCEPTS: p-value (probability that the observed result occurred by chance; p<0.05 is conventional threshold but does NOT indicate clinical significance); confidence interval (range within which the true population value likely falls; narrower CI = more precise estimate; if CI for risk difference crosses zero, the result is NOT statistically significant); absolute risk reduction (ARR = control event rate - experimental event rate); relative risk reduction (RRR = ARR/control event rate; can be misleading because a 50% RRR sounds impressive but may represent an ARR of only 0.5%); NNT = 1/ARR (how many patients must be treated for one to benefit). QUALITY IMPROVEMENT (QI) methodology applies the Plan-Do-Study-Act (PDSA) cycle to implement evidence-based changes in clinical practice: Plan (identify the problem and design the intervention), Do (implement the change on a small scale), Study (analyze the results), Act (adopt, adapt, or abandon the change based on results).

Diagnosis & workup

Diagnostics & workup: - Systematic literature search: use PICO to structure the search; access reliable databases (PubMed/MEDLINE, CINAHL, Cochrane Library, UpToDate, DynaMed); use MeSH terms and Boolean operators (AND, OR, NOT) for precision; apply filters (systematic reviews, RCTs, date range, human subjects); evaluate at least 2-3 high-quality sources before changing practice - Critical appraisal of a randomized controlled trial: Was randomization truly random and concealed? Were groups similar at baseline? Were participants and assessors blinded? Was follow-up adequate (attrition <20%)? Was analysis by intention-to-treat? Were outcomes clinically relevant (not just surrogate markers)? Was the sample size adequate (power calculation reported)? - Critical appraisal of a systematic review/meta-analysis: Was the clinical question focused? Was the search comprehensive (multiple databases, grey literature)? Was study quality assessed (risk of bias tool)? Were results combined appropriately (heterogeneity assessed with I-squared statistic -- I² >75% = substantial heterogeneity)? Was a funnel plot assessed for publication bias? - Clinical practice guideline evaluation: use the AGREE II instrument; Was the scope clearly defined? Was there systematic evidence review? Were recommendations clearly linked to evidence quality? Were benefits and harms considered? Was there an explicit process for updating? Were conflicts of interest disclosed and managed? - Outcome measurement and quality metrics: identify appropriate outcome measures for QI projects (process measures vs. outcome measures vs. balancing measures); use validated measurement tools; establish baseline data before implementing changes; apply statistical process control (SPC) charts to distinguish common cause from special cause variation - Needs assessment for practice change: identify the gap between current practice and best evidence; use clinical audit data, patient outcome reports, staff surveys, patient satisfaction data, and comparison to benchmarks/national quality indicators to quantify the gap and build the case for change

Risk factors: - Barriers to EBP implementation: lack of time for literature searching and critical appraisal during clinical practice, inadequate training in research methodology and statistics, organizational resistance to change, limited access to full-text research databases, difficulty translating research findings into actionable clinical protocols - Knowledge-to-practice gap: the average time for research findings to be incorporated into routine clinical practice is 17 YEARS (Balas & Boren, 2000); this gap means patients frequently receive care that is not based on the best available evidence; implementation science seeks to close this gap through structured strategies - Publication bias: studies with positive results are more likely to be published than studies with negative or equivocal results; this distorts the evidence base by overrepresenting the effectiveness of interventions; the NP must consider the possibility that the published literature may not reflect the totality of evidence - Over-reliance on expert opinion: despite being the lowest level of evidence, expert opinion and 'the way we've always done it' continue to drive many clinical practices; the NP must critically evaluate whether current practices are supported by higher levels of evidence - Statistical vs. clinical significance: a study may show a statistically significant result (p<0.05) that is not clinically meaningful; conversely, a clinically important effect may fail to reach statistical significance due to inadequate sample size; the NP must evaluate BOTH statistical and clinical significance when appraising evidence - Misapplication of research to individual patients: population-level evidence may not apply to every individual patient; the NP must consider patient-specific factors (comorbidities, preferences, values, social circumstances) that may modify the applicability of research findings

Clinical meaning

Your next step on PMHNP

Practice this topic

Review related lessons

PMHNP CAT

Diagnosis & workup

Management

Prescribing & monitoring

Takeaways

Your next step on PMHNP

Practice this topic

Review related lessons

PMHNP CAT

Clinical meaning

Practice questions for this topic

Your next step on PMHNP

Practice this topic

Review related lessons

PMHNP CAT

Diagnosis & workup

Practice questions for this topic

Your next step on PMHNP

Practice this topic

Review related lessons

PMHNP CAT